Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Summary

This phase II trial is studying how well sunitinib works in treating patients with advanced malignant mesothelioma of the pleura. Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.

Timeline

Start

2007-02

Primary completion

2012-01

Completion

2012-01

Drugs

Indications